{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "40032-016",
      "generic_name": "DICLOFENAC SODIUM",
      "labeler_name": "Novel Laboratories, Inc.",
      "brand_name": "DICLOFENAC SODIUM",
      "active_ingredients": [
        {
          "name": "DICLOFENAC SODIUM",
          "strength": "16.05 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "40032-016-61",
          "description": "1 BOTTLE in 1 CARTON (40032-016-61)  / 150 mL in 1 BOTTLE",
          "marketing_start_date": "20151209",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Novel Laboratories, Inc."
        ],
        "rxcui": [
          "857700"
        ],
        "spl_set_id": [
          "c99f5ef6-c777-4896-a5e7-7335257439b2"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "QTG126297Q"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "SOLUTION",
      "spl_id": "878c2746-64ac-4cf5-a8d6-25b2799b5891",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "TOPICAL"
      ],
      "marketing_start_date": "20151209",
      "product_id": "40032-016_878c2746-64ac-4cf5-a8d6-25b2799b5891",
      "application_number": "ANDA205878",
      "brand_name_base": "DICLOFENAC SODIUM",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]"
      ]
    }
  ]
}